Complete Remission Obtained with Azacitidine in a Patient with Concomitant Therapy Related Myeloid Neoplasm and Pulmonary Mucormycosis

by Saveria Capria, Federico De Angelis, Giuseppe Gentile, Silvia Maria Trisolini, Simonetta Brocchieri, Martina Canichella, Patrizia Chiusolo, Alessandra Micozzi, Robin Foà, Giovanna Meloni
Published 2013-07-01

Cytogenetic effect of 5-azacytidine in patients with hematological malignancies

by Jessica Romy Tsuda, Rosimeire Segato, Waldênia Barbosa, Marília de Arruda Cardoso Smith, Spencer Luiz Marques Payão
Published 2011-10-01

The Impact of the Epigenetic Cancer Drug Azacitidine on Host Immunity: The Role of Myelosuppression, Iron Overload and <i>tp53</i> Mutations in a Zebrafish Model

by Shu-Ching Wang, Ching-Tse Wu, Dong-Yu Wu, Caleb Gon-Shen Chen, Kuo-Ming Chang, Chien-Chung Chang
Published 2019-09-01

Demethylating Agents in the Treatment of Cancer

by Paul M. Howell, Jr., Zixing Liu, Hung T. Khong
Published 2010-07-01

PREVENTING INFECTIONS IN HIGHER-RISK MYELODYSPLASTIC SYNDROME PATIENTS TREATED WITH HYPOMETHYLATION AGENTS

by Yishai Ofran
Published 2013-08-01

Impact of the relative dose intensity on survival of patients with high‐risk myelodysplastic syndromes treated with Azacitidine

by Kamel Laribi, Delphine Bolle, Mustafa Alani, Habib Ghnaya, Anne Besançon, Jonathan Farhi, Kayane Mheidly, Nathalie Denizon, Alix Baugier de Materre
Published 2019-05-01

Indefinite Azacitidine Treatment Until Progression May Provide Long-Term Disease Control in Elderly Patients with Acute Myelogenous Leukemia

by Ali ESER, Aslıhan SEZGİN, Osman KARA, Süheyla UYAR BOZKURT
Published 2018-07-01

Managing myelodysplastic syndromes in very old patients: a teaching case report

by Niscola P, Palombi M, Trawinska MM, Tendas A, Giovannini M, Scaramucci L, Perrotti A, de Fabritiis P
Published 2013-04-01

Stability of 25 mg/mL Azacitidine Suspensions Kept in Fridge after Freezing

by Balouzet Clara, Chanat Cédric, Jobard Marion, Brandely-Piat Marie-Laure, Chast François
Published 2017-03-01

MRD negative CR after azacitidine and venetoclax in a young patient with AML, unfit for intensive induction followed by ASCT

by Deepak Kumar Shukla, Satyendra Katewa, Ravikant Porwal, Ravi Dara, Lalit Sharma, Rahul Sharma, Aadesh Arora
Published 2021-01-01

A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine

by Chiara R. Dart, Nabanita Mukherjee, Carol M. Amato, Anabel Goulding, Morgan MacBeth, Robert Van Gulick, Kasey L. Couts, James R. Lambert, David A. Norris, William A. Robinson, Yiqun G. Shellman
Published 2021-07-01

Bridging-to-transplant with azacitidine for myelodysplastic syndrome and acute myeloid leukemia, reduces the incidence of acute graft-versus-host disease

by Koichi Murakami, Hironori Ueno, Takashi Okabe, Toshiya Kagoo, Saigen Boku, Takahiro Yano, Akihiro Yokoyama
Published 2017-06-01

INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY

by Giuseppe Leone, Livio Pagano, Livio Pagano
Published 2018-07-01

AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA: AN EFFECTIVE AND MANAGEABLE APPROACH.

by Pasquale Niscola
Published 2014-02-01

Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial

by Farhad Ravandi, Gail J. Roboz, Andrew H. Wei, Hartmut Döhner, Christopher Pocock, Dominik Selleslag, Pau Montesinos, Hamid Sayar, Maurizio Musso, Angela Figuera-Alvarez, Hana Safah, William Tse, Sang Kyun Sohn, Devendra Hiwase, Timothy Chevassut, Francesca Pierdomenico, Ignazia La Torre, Barry Skikne, Rochelle Bailey, Jianhua Zhong, C. L. Beach, Herve Dombret
Published 2021-08-01

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Aust...

by Lisa Pleyer, Hartmut Döhner, Hervé Dombret, John F. Seymour, Andre C. Schuh, CL Beach, Arlene S. Swern, Sonja Burgstaller, Reinhard Stauder, Michael Girschikofsky, Heinz Sill, Konstantin Schlick, Josef Thaler, Britta Halter, Sigrid Machherndl Spandl, Armin Zebisch, Angelika Pichler, Michael Pfeilstöcker, Eva M. Autzinger, Alois Lang, Klaus Geissler, Daniela Voskova, Wolfgang R. Sperr, Sabine Hojas, Inga M. Rogulj, Johannes Andel, Richard Greil
Published 2017-02-01

Myelodysplastic syndromes: therapeutic problems and decisions (review)

by S. V. Semochkin, T. N. Tolstykh, A. G. Rumyantsev
Published 2014-07-01

Successful long-term treatment with azacitidine in patient with chronic myelomonocytic leukemia

by Luka Čemažar, Helena Podgornik, Njetočka Gredelj Šimec, Samo Zver
Published 2020-12-01

A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic...

by Claire Horgan, Alexandros Kanellopoulos, Shankara Paneesha, Bhuvan Kishore, Richard Lovell, Emmanouil Nikolousis
Published 2019-02-01

A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

by Jehad Almasri, Hassan B. Alkhateeb, Belal Firwana, Mohamad Bassam Sonbol, Moussab Damlaj, Zhen Wang, M. Hassan Murad, Aref Al-Kali
Published 2018-09-01